<SEC-DOCUMENT>0001169245-22-000013-index.html : 20220228 <SEC-HEADER>0001169245-22-000013.hdr.sgml : 20220228 <ACCEPTANCE-DATETIME>20220228192512 ACCESSION NUMBER: 0001169245-22-000013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220224 FILED AS OF DATE: 20220228 DATE AS OF CHANGE: 20220228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Birchall Jonathan CENTRAL INDEX KEY: 0001892776 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38697 FILM NUMBER: 22692950 MAIL ADDRESS: STREET 1: C/O PHASEBIO PHARMACEUTICALS, INC. STREET 2: 1 GREAT VALLEY PARKWAY, SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc CENTRAL INDEX KEY: 0001169245 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 030375697 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (610) 981-6500 MAIL ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: Phase Biosciences Inc DATE OF NAME CHANGE: 20061013 FORMER COMPANY: FORMER CONFORMED NAME: DT BIOSCIENCES INC DATE OF NAME CHANGE: 20020315 </SEC-HEADER> <DOCUMENT> <TYPE>4 <SEQUENCE>1 <FILENAME>wf-form4_164609429220987.xml <DESCRIPTION>FORM 4 <TEXT> Document 1 - file: wf-form4_164609429220987.html
Document 1 - RAW XML: wf-form4_164609429220987.xml
</DOCUMENT> </SEC-DOCUMENT>